COMT and OPRM1 Genotype Associations with Daily Knee Pain Variability and Activity Induced Pain by Martire, Lynn M et al.
University of South Florida
Scholar Commons
Aging Studies Faculty Publications School of Aging Studies
1-1-2016
COMT and OPRM1 Genotype Associations with
Daily Knee Pain Variability and Activity Induced
Pain
Lynn M. Martire
The Pennsylvania State University
Stephanie J. Wilson
The Pennsylvania State University
Brent J. Small
University of South Florida, bsmall@usf.edu
Yvette P. Conley
University of Pittsburgh
Piotr K. Janicki
Penn State College of Medicine
See next page for additional authors
Follow this and additional works at: http://scholarcommons.usf.edu/gey_facpub
Part of the Gerontology Commons, and the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the School of Aging Studies at Scholar Commons. It has been accepted for inclusion in Aging
Studies Faculty Publications by an authorized administrator of Scholar Commons. For more information, please contact scholarcommons@usf.edu.
Scholar Commons Citation
Martire, Lynn M.; Wilson, Stephanie J.; Small, Brent J.; Conley, Yvette P.; Janicki, Piotr K.; and Sliwinski, Martin J., "COMT and
OPRM1 Genotype Associations with Daily Knee Pain Variability and Activity Induced Pain" (2016). Aging Studies Faculty
Publications. 13.
http://scholarcommons.usf.edu/gey_facpub/13
Authors
Lynn M. Martire, Stephanie J. Wilson, Brent J. Small, Yvette P. Conley, Piotr K. Janicki, and Martin J. Sliwinski
This article is available at Scholar Commons: http://scholarcommons.usf.edu/gey_facpub/13
COMT and OPRM1 Genotype Associations with Daily Knee Pain 
Variability and Activity Induced Pain
Lynn M. Martire, PhD and Stephanie J. Wilson, MS
The Pennsylvania State University
Brent J. Small, PhD,
University of South Florida
Yvette P. Conley, PhD,
University of Pittsburgh
Piotr K. Janicki, MD, PhD, and
Penn State College of Medicine
Martin J. Sliwinski, PhD
The Pennsylvania State University
Abstract
Background—Osteoarthritis (OA) of the knee is a common and increasingly prevalent condition 
that is one of the primary causes of chronic pain. Staying physically active protects against 
disability from knee OA but is also very challenging. A critical but unexamined question is 
whether patients at greatest risk for becoming less active are those with a genetic predisposition 
for greater sensitivity to daily pain.
Aims—We examined day-to-day variability in knee OA pain for patients with different variants 
of catechol-O-methyltransferase (COMT) and mu-opioid receptor (OPRM1) single nucleotide 
polymorphisms (SNPs), and whether patients with a specific genotype experience more pain 
following daily physical activity. We predicted that patients having one or more copies of the 
Met158 allele of COMT rs4680 (A-A or A-G) and one or more copies of the Asp40 allele of 
OPRM1 rs1799971 (A-G or G-G) would show greater pain variability. We expected to see the 
same pattern for these SNPs with regard to moderation (i.e., exacerbation) of the activity-pain 
association.
Methods—A total of 120 knee OA patients reported on their pain 3 times per day over 22 days 
using handheld computers, and wore an accelerometer to capture daily physical activity. 
Multilevel modeling was used to examine the magnitude of within-person variability in pain by 
genetic group. We also examined whether lagged, within-patient associations between level of 
activity in the afternoon (i.e., minutes of moderate intensity activity, and number of steps) and 
knee pain at the end-of-day were moderated by between-patient differences in genotype.
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Results—Regarding OPRM1 rs1799971 (Asn40Asp), patients with two copies of the Asn40 allele 
showed the greatest day-to-day pain variability. Regarding COMT rs4680 (Val158Met), patients 
with the Val/Val genotype showed the greatest pain variability and also experienced the greatest 
increase in pain as a result of physical activity. A similar pattern of findings across bi-directional 
temporal lags was consistent with a negative feedback loop between daily physical activity and 
pain according to genotype. Consistent with some previous studies, there were no significant 
between-person differences in daily pain when comparing patients according to COMT rs4680, or 
OPRM1 rs1799971.
Conclusion—This study provides preliminary evidence that patients with certain genotypes for 
COMT rs4680 and OPRM1 rs1799971 (G-G and A-A, respectively) experience more variability in 
their day-to-day pain and exacerbation of pain after daily physical activity compared to patients 
with other genotypes. Our findings should be replicated in larger study populations.
Implications—Previous clinical research has focused primarily on differences in average level 
of pain between patients with and without a specific genotype. Assessment of within-person 
variability through repeated measurements in daily life enhances the reliability, power, and 
ecological validity of phenotypic measurement.
Keywords
pain; genetics; ambulatory; osteoarthritis; physical activity
Introduction
Osteoarthritis (OA) of the knee is a common and increasingly prevalent condition that is one 
of the primary causes of chronic pain (Murphy et al., 2008). Staying physically active 
protects against disability from knee OA but is also very challenging (Dunlop et al., 2005; 
Messier et al., 2004). A critical but unexamined question is whether patients at greatest risk 
for becoming less active are those with a genetic predisposition for greater sensitivity to 
daily pain. In the present study we examined day-to-day variability in knee OA pain for 
patients with different variants of catechol-O-methyltransferase (COMT) and mu-opioid 
receptor (OPRM1) single nucleotide polymorphisms (SNPs). We also examined the 
moderation of associations between daily physical activity and knee pain by genotype.
Research on genetics and pain sensitivity has often focused on COMT rs4680 (Val158Met), a 
polymorphism of the COMT gene. Relatively little of this research has been in OA. In one 
study, having one or more copies of the Met158 allele (Met/Met or Val/Met; i.e., A-A or A-
G) was associated with greater hip OA pain in women (van Muers et al., 2009). However, a 
second study did not find an association between symptomatic knee OA and Val158Met 
(Neogi et al., 2014). Another focus of research on pain sensitivity is the OPRM1 rs1799971 
(Asn40Asp, A118G) polymorphism (Henker et al., 2013; Janicki et al., 2006). As with 
COMT rs4680, virtually none of this research has been in OA. Being homozygous for the 
Asp40 allele of this polymorphism (G-G) has been linked with greater opioid analgesic 
requirements for pain relief after total knee arthroplasty (Chou et al., 2006).
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Previous research on genetics and pain sensitivity has focused primarily on between-person 
differences by examining differences in average pain severity between individuals with and 
without an at-risk genotype. An equally important question, and the first focus of the current 
study, is whether patients with an at-risk genotype are more variable in their day-to-day pain 
(i.e., within-person differences; Finan, Tennen, Thoemmes, Zautra, & Davis, 2012). To our 
knowledge, only one previous study has taken this approach, showing greater within-person 
variability in daily pain for fibromyalgia patients with two copies of the Met158 allele of 
COMT (A-A), and no differences across variants in OPRM1 rs1799971 (Finan et al., 2010, 
2011). In the current study we used ambulatory data collected from knee OA patients 3 
times per day over 22 days to examine the relationships of OPRM1 rs1799971 and COMT 
rs4680 allelic differences with day-to-day (i.e., within-person) variability in knee pain.
Greater fluctuations in pain, regardless of the level of pain, are likely to reflect greater 
sensitivity to activities throughout the day. Although previous experimental studies have 
shown that walking tests increase the level of pain (Wideman et al., 2014), it is not clear if 
typical daily activity is associated with increased pain for individuals with a specific 
genotype. Thus, the second novel aim of our study was to determine if knee OA patients 
with a specific genotype experience more pain following daily physical activity. These 
analyses incorporated accelerometer data collected over 22 days in tandem with daily pain 
data. Specifically, we examined lagged, within-patient associations between level of 
physical activity in the afternoon (i.e., minutes of moderate intensity activity, and number of 
steps) and knee pain ratings at the end-of-day, and moderation of these associations by 
genotype. We predicted that patients having one or more copies of the Met158 allele of 
COMT rs4680 (A-A or A-G) and one or more copies of the Asp40 allele of OPRM1 
rs1799971 (A-G or G-G) would show greater pain variability. We expected to see the same 
pattern for these SNPs with regard to moderation (i.e., exacerbation) of the activity-pain 
association.
Method
Participants
Data presented in this report are from a prospective observational (i.e., non-intervention) 
study of knee OA patients and their spouses. The purpose of the larger study was to examine 
spousal influence on osteoarthritis patients’ daily and long-term functioning; for a detailed 
description, see Martire et al. (2013). The current report focuses only on patients. To be 
eligible for the study, patients had to be diagnosed with knee OA by a physician, experience 
usual knee pain of moderate or greater intensity, be at least 50 years of age, and be married 
or in a long-term relationship (self-defined) in which they shared a residence with their 
partner. Exclusion criteria were a comorbid diagnosis of fibromyalgia or rheumatoid arthritis 
and use of a wheelchair to get around. Primary sources of recruitment were research 
registries for rheumatology clinic patients and older adults interested in research, flyers 
distributed to University of Pittsburgh staff and faculty, and word of mouth. A total of 606 
couples were screened for eligibility. Of these, 221 couples declined to participate, and the 
most frequent reasons were lack of interest (N=87) or illness in the family (N=55). A total of 
233 couples were not eligible, and the most frequent reasons were lack of osteoarthritis in 
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the knee (N=55) or knee osteoarthritis pain that was mild (N=47). The total enrolled sample 
for the larger study was 152 couples.
A total of 145 patients completed the diary assessment and accelerometry components of the 
study and 120 of these patients agreed to DNA collection as an optional component of the 
study. Of these patients, 114 had data for OPRM1 rs1799971 and 120 had data for COMT 
rs4680. Patients with genetic data were compared with the larger phenotyped cohort who did 
not have genetic data on demographic and illness characteristics (age, sex, ethnicity, years of 
education, employment status, income, duration of knee OA and severity of knee OA). A 
greater proportion of patients in the genotyped group were not currently employed, X2 (1) = 
4.93, p = .027. This likely reflects that genetic data collection often required a separate visit 
to participants’ homes during the day, when employed participants were less likely to be 
home, rather than a substantive bias in the cohort. No other differences were found between 
the two groups.
The University of Pittsburgh Institutional Review Board (IRB) approved this study, and an 
IRB-approved form was used to obtain written informed consent from all participants. Penn 
State University’s IRB approved the storage of data on Penn State servers and continued 
analysis of study data.
Data Collection Procedures
During a 22-day assessment protocol, patients used a handheld computer to answer 
questions about pain at the beginning-of-day, in the afternoon (between 2:00 and 4:00 p.m.), 
and at end-of-day (i.e., upon retiring to bed). Completion and compliance rates for the diary 
data were over 90% (Martire et al., 2013).
Measures
Daily knee pain—Patients provided reports of knee pain over the past 30 minutes on a 
scale from 0 to 3 (no pain to severe pain) at the beginning of day, afternoon, and end of day. 
We also computed a score for pain across the day by averaging the three ratings. The knee 
pain measure is taken from the Rapid Assessment of Disease Activity in Rheumatology 
(Mason et al., 1992) and is often used in daily assessment research. Average daily knee pain 
for all patients was mild to moderate (M = 1.44; SD = .75; range = 0 - 3). Mean levels of 
morning, afternoon, and evening knee pain were consistent with those averaged across the 
day (Mmorning = 1.33, SD = 0.80, range = 0 - 3; Mafternoon = 1.42, SD = 0.80, range = 0 - 3; 
Mevening = 1.45, SD = 0.74, range = 0 – 3).
Physical activity—Accelerometers were used to assess amount of time spent in moderate-
intensity activity and daily steps taken during the 22-day assessment period. Accelerometers 
are motion-sensitive monitors that count the number of movements or steps taken per pre-
specified time interval. Self-reports of physical activity are often overestimated (Ewald, 
McEvoy, & Attia, 2010), and thus accelerometers are considered the best way to objectively 
measure free-living physical activity (Matthews, Ainsworth, Thompson, & Bassett Jr., 2002; 
Troiano et al., 2008). Participants wore the GT1M or GT3X model of the CSA/MTI tri-axial 
Martire et al. Page 4
Scand J Pain. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
ActiGraph, with placement on the hip in order to best capture ambulatory activities (Swartz 
et al., 2000). Data were collected in 1-minute epochs.
Patients were instructed to wear the monitor during the day and remove it at night; a 
reminder to put the monitor on in the morning was provided electronically via the handheld 
computers. Participants used a written log to record any periods during which they did not 
wear the accelerometer. All times when the monitor was not worn were removed from data 
analysis. Data were then screened for anomalous values (activity counts greater than 6000 at 
any given minute), which affected less than 1% of the activity data. The average number of 
days that the accelerometer was worn was 17.5 (SD = 4.0).
Intensity of physical activity is commonly defined using an activity count cut point that 
corresponds to a range of metabolic equivalents. Previous work confirms that the common 
cut point for moderate intensity activity (1,952 or more activity counts per minute) 
underestimates walking intensity in older adults as measured by oxygen consumption during 
treadmill tests (Brach, Wert, VanSwearingen, & Studenski, 2009). Thus, as reported in a 
previous publication (Martire et al., 2013), we relied on work by Matthews (2005) and 
Matthews and colleagues (2002) which combined information from laboratory and field 
studies to determine a cut point that may better capture moderate-intensity activities of daily 
living for older adults. Specifically, we defined 760 activity counts per minute or greater as 
moderate-intensity activity (i.e., moderate-to-vigorous, hereafter referred to as moderate for 
simplicity). During the afternoon-to-evening epoch that was used for analysis (henceforth 
called afternoon physical activity for simplicity), the average number of minutes spent in 
moderate physical activity was 17.08 (SD = 23.03), and the average number of steps taken 
was 1815.71 (SD = 1528.38).
DNA Extraction and Genotyping
Saliva was collected using the Oragene DNA collection kit (DNA Genotek; Ontario, 
Canada) and DNA was extracted from the saliva according to the manufacturer’s 
instructions.
COMT genotyping—We genotyped COMT rs4680 (Val158Met ). We used TaqMan 5′ 
exonuclease Assay-on-Demand assays (Applied Biosystems Inc., ABI, Foster City, CA), the 
ABI7000 for amplification and data collection, and SDS 2.0 software (ABI) for genotype 
assignment.
OPRM1 genotyping—We genotyped three polymorphisms within OPRM1, including 
rs1799971 (Asn40Asp or A118G), rs1799973 (G24A), and rs1799972 (C17T), but we report 
results for only OPRM1 rs1799971 due to low or zero frequency of the minor alleles for 
rs1799973 and rs1799972 in the study cohort. SNPs were genotyped by sequencing a 101bp 
polymerase chain reaction (PCR) product generated from exon 1 where all 3 investigated 
polymorphisms reside. Primers to generate the PCR product in the forward and reverse 
direction were 5′-TCAGTACCATGGACAGCAG-3′ and 5′-
GGAGTAGAGGGCCATGAT-3′ respectively. ExoSAP reagents (USBiochemicals, 
Cleveland, OH) were used to clean up the PCR product and Big Dye Cycle Sequencing 
reagents (ABI) with the reverse primer were used to sequence the PCR product. Sequencing 
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was conducted with an ABI377 automated sequencer (ABI). Sequencer software (Gene 
Codes Corporation, Ann Arbor, MI) was used to visualize the sequence and assign 
genotypes.
For all genotyping conducted for this research, we made double-masked genotyping 
assignments for each variant, compared them, and addressed each discrepancy using raw 
data or by re-genotyping.
Data Analysis
Prior to the analysis of the knee pain data, we assessed Hardy–Weinberg equilibrium for all 
genotypes. Multilevel modeling (Raudenbush & Bryk, 2002) with SAS PROC MIXED was 
used to examine within-person variability in daily knee pain, lagged associations between 
daily physical activity and knee pain, and moderation of these associations by COMT rs4680 
and OPRM1 rs1799971. To address the first hypothesis, we fit heterogeneous variance 
multilevel models to assess whether the magnitude of within-person variability in pain 
differed by genetic group (Hoffman, 2007). These models also tested for differences in 
average daily knee pain by genotype in order to allow for direct comparisons to previous 
studies that have taken this approach.
In tests of the second hypothesis regarding lagged associations between physical activity and 
pain, end-of-day knee pain was modeled as a function of patient physical activity during the 
afternoon (within-person centered), genotype, and the interaction between physical activity 
and genotype. These models allowed us to determine whether within-patient associations 
between physical activity and knee pain were moderated by between-patient differences in 
genotype. Minutes of moderate physical activity were scaled by 60, such that a one-unit 
increase is equivalent to 60 minutes. Steps were scaled by 100, such that a one-unit increase 
is equivalent to 100 steps. Random intercepts and random slopes of activity, genotype, and 
the interaction between activity and genotype were tested. These models also included 
heterogeneous variance terms from the prior set of models. In secondary analyses we tested 
the reverse temporal order of afternoon ratings of knee pain predicting level of physical 
activity during the remainder of the day, and moderation by genotype.
All analyses controlled for age, sex and race (White versus non-White). In addition, each 
participant’s diary days were consecutively numbered and this variable was included in the 
analyses to adjust for potential linear effects of repeated assessments. Secondary analyses 
excluding non-White participants (N = 15) were conducted to test the generalizability of 
study results for Whites only.
Results
Sample Characteristics
Table 1 summarizes sample characteristics. On average, participants were 65 years of age, 
half were male and they had completed 16 years of education. Approximately 88% were 
White and the remainder were Black/African American (n = 12, with 1 also identifying as 
Hispanic) or American Indian/Alaskan native (n = 3, with 1 also identifying as White). 
Participants reported having OA for almost 13 years on average and arthritis severity was 
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moderate according to scores on the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC; Bellamy, Buchanan, Goldsmith, Campbell, & Stitt, 1988).
Genotype Frequencies
The frequencies for OPRM1 rs1799971 and COMT rs4680 are shown in Table 2. Analyses 
showed that both polymorphisms were in Hardy-Weinberg equilibrium (p > .10) indicating 
that the distribution of alleles did not significantly vary from population expectations.
Genotypic Differences in Daily Pain Variability
The intraclass correlation (ICC) indicates the variance attributed to between-person 
differences, and 1-ICC reflects the proportion of within-person differences. According to 
ICCs, within-person differences accounted for approximately 36% of the variance in pain at 
the beginning-of-day, afternoon, and end-of day assessments.
Table 3 displays the within-person estimate, standard error, and statistical significance for 
pain at each assessment according to COMT rs4680 and OPRM1 rs1799971. As shown in 
this table, greater day-to-day (i.e. within-person) variability was found in patients with a 
particular genotype. The first set of columns show that, contrary to our prediction, there was 
greater within-person variability in afternoon, end-of-day, and across-the-day knee pain for 
patients with two copies of the Val158 allele (G-G) compared to those with at least one copy 
of Met158 (A-A or A-G; estimateAft = −0.24, SE = 0.07, p = .001; estimateEnd = −0.28, SE = 
0.07, p = .0002; estimateAvg = −0.15, SE = 0.07, p = .03). The difference for beginning-of-
day pain was not significant (p = .16).
Findings for OPRM1 rs1799971 are presented in the second set of columns in Table 3. We 
predicted that having one or more copies of the Asp40 allele (A-G or G-G) would be 
associated with greater pain variability. Contrary to prediction, patients who were 
homozygous for the Asn40 allele (A-A) varied more within-person in their knee pain in the 
morning, evening, and on average across the day than did those with one copy of the Asp40 
allele (A-G; ps = .009 to .037). The effect was not significant for afternoon pain but trended 
in the same direction (p = .084).
Analysis of between-person variability in daily knee pain
Consistent with some previous studies (Finan et al., 2010, 2011; Neogi et al., 2014; Nicholl 
et al., 2010), there were no significant between-person differences in daily pain when 
comparing patients according to COMT rs4680, or OPRM1 rs1799971 (p > .25).
Differences in Lagged Associations between Daily Physical Activity and Knee Pain by 
Genotype
Table 4 presents the fixed effects for each of the predictors in the lagged multilevel models 
(i.e., main effects of physical activity and genotype, and the interaction between these 
terms). Because no analyses converged with the inclusion of random slopes, only random 
intercepts were estimated in final models.
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The first set of columns in Table 4 present the multilevel results for COMT rs4680. These 
analyses showed that COMT rs4680 was a significant moderator of the relationship between 
minutes of afternoon physical activity and end-of-day pain severity (p = .014). This finding 
is depicted in Figure 1. Contrary to our prediction, but consistent with our finding for daily 
pain variability, patients with two copies of the Val158 allele (G-G) had significantly higher 
pain at the end of day following more minutes of moderate physical activity (estimate = 
0.30, SE = 0.11, p = .007) whereas those with at least one copy of Met158 (A-A or A-G) did 
not experience significant changes in pain following more moderate physical activity 
(estimate = −0.002, SE = 0.05, p = .97). COMT rs4680 did not moderate the association 
between number of steps taken during the afternoon and end-of-day pain severity.
The second set of columns in Table 4 show the multilevel results for OPRM1 rs1799971. 
This genotype did not moderate the association of afternoon moderate activity with end-of-
day knee pain. Our finding for number of steps was contrary to prediction but consistent 
with our finding for daily pain variability. That is, those with two copies of the Asn40 allele 
(A-A) reported significantly more pain at the end of the day after taking more steps in the 
afternoon (estimate = 0.004, SE = 0.001, p = .010), whereas those with the Asp40 allele of 
the polymorphism (A-G) did not show an association between afternoon steps and end-of-
day pain (estimate = −0.001, SE = 0.002, p = .64). However, the interaction between steps 
and OPRM1 rs1799971 did not reach statistical significance (p = .085).
Reverse temporal order—We also examined the effects of afternoon knee pain on 
physical activity between the afternoon and end-of-day, and their moderation by genotype. 
No interactions were statistically significant, but some findings trended in the expected 
direction. Regarding COMT rs4680, patients with two copies of the Val158 allele (G-G) 
engaged in fewer minutes of moderate physical activity after greater afternoon knee pain 
(estimate = −0.06, SE = 0.02, p = .018) whereas those with at least one copy of Met158 (A-A 
or A-G) did not show an association between afternoon knee pain and minutes of moderate 
activity (estimate = −0.01, SE = 0.02, p = .40, pinteraction = .13). Patients with Val/Val also 
took fewer steps after greater afternoon knee pain (estimate = −2.35, SE = .96, p = .014), but 
patients with Val/Met did not experience a significant association between afternoon pain 
and steps (estimate = −0.51, SE = 0.63, p = .42; pinteraction = .11). This similar pattern of 
findings across bi-directional temporal lags is consistent with a negative feedback loop 
between daily physical activity and pain according to genotype.
Subgroup Analyses
Because we were not able to compare White and Non-White participants, secondary 
analyses focused on only Whites were conducted to determine if population stratification is 
a threat to the validity of study findings. Two differences emerged in our variability 
findings. A non-significant difference in pain at the beginning of day for COMT rs4680 in 
all patients (estimate = −0.11, SE = 0.07, p = .160) was statistically significant in Whites 
only (estimate = −0.16, SE = 0.08, p = .049). Also, a non-significant effect of OPRM1 
rs1799971 on afternoon pain variability in the full sample (estimate = 0.13, SE = 0.08, p = .
084) was statistically significant in the Whites-only subsample (estimate = 0.19, SE = 0.08, 
p = .015). Findings for the interactions between genotype and physical activity were 
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consistent across Whites-only and full samples. There were no significant between-person 
differences in daily pain by genotype for Whites only (ps > .17), consistent with the analyses 
that included all patients.
Discussion
It is estimated that nearly half of U.S. adults will develop symptomatic knee OA in their 
lifetime (Murphy et al., 2008). For these individuals, a genetic predisposition for greater 
sensitivity to daily pain may be a risk factor for physical disability due to inactivity and 
deconditioning. To our knowledge, this is the first study to examine associations between 
daily knee OA pain and physical activity by genotype. Although our findings should be 
replicated in larger study populations, this study provides preliminary evidence that patients 
with certain genotypes for COMT rs4680 and OPRM1 rs1799971 (G-G and A-A, 
respectively) experience more variability in their day-to-day pain and exacerbation of pain 
after daily physical activity compared to patients with other genotypes.
Previous clinical research has focused primarily on differences in average level of pain 
between patients with and without a specific genotype. Our study posed additional questions 
and offers several advantages over previous approaches. As noted by Finan and colleagues 
(2012), assessment of within-person variability through repeated measurements in daily life 
enhances the reliability, power, and ecological validity of phenotypic measurement and 
helps to reduce threats to detecting true gene-phenotype associations (Finan et al., 2012). 
Consistent with a previous study on knee OA (Neogi et al., 2014), we found no significant 
mean differences in pain severity between genetic groups.
Our first aim was to examine differences in daily pain variability by genotype. In our 
analyses focused on the rs4680 SNP of the COMT gene, we found greater within-person 
variability in afternoon, end-of-day, and across-the-day knee pain for patients with two 
copies of the Val158 allele (G-G), controlling for average level of pain. This finding is 
contrary to a previous study of hip OA that examined between-group differences in pain 
(van Muers et al., 2009). It is important to keep in mind that variability between and within 
patients reflect different phenomena (Curran & Bauer, 2011).
Our analyses on the rs1799971 SNP of the OPRM1 gene showed a consistent direction of 
effect across time points within the day. Patients who were homozygous for the Asn40 allele 
(A-A) showed more variability in knee pain than did those with one copy of the Asp40 allele 
at the beginning of day, end of day, and across the day. We had predicted that the Asp40 
allele would be associated with greater pain variability, but this prediction was based on one 
study of morphine consumption after knee arthroplasty that examined between-group 
differences in pain (Chou et al., 2006).
Greater fluctuations in pain, regardless of the level of pain, are likely to reflect greater 
sensitivity to activities throughout the day. Thus, our second aim was to determine if daily 
physical activity is more strongly associated with higher levels of pain for patients with a 
specific genotype. We found that patients with the Val/Val genotype (G-G) for COMT 
rs4680 were not only most variable in their pain but also experienced the greatest increase in 
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pain as a result of physical activity. Similarly, there was a trend-level finding that patients 
with two copies of the Asn40 allele (A-A) for OPRM1 rs1799971 were most variable in their 
pain and also experienced greater pain at the end of the day after taking more steps in the 
afternoon. These findings for COMT rs4680 and OPRM1 rs1799971 are consistent with the 
idea that greater variability in pain experienced during daily life reflects more sensitivity to 
physical activity.
These findings extend the experimental literature which shows that walking tests increase 
the level of pain (Wideman et al., 2014) by demonstrating that typical daily activity may be 
associated with increased pain for individuals with a specific genotype. The lagged, 
bidirectional associations between physical activity and pain that were detected in our 
secondary analyses suggest that there is a negative feedback loop such that activity leads to 
increased pain and pain leads to decreased activity. This study marks an important step 
toward understanding how the daily experience and consequences of pain and physical 
activity may differ for osteoarthritis patients with different genotypes. Smaller differences 
were detectable with greater power by the use of a repeated-measures design and a 
commensurate multilevel modeling approach (Finan et al., 2012). This is consistent with a 
previous gene-behavior study of a similar design that found clinically interesting differences 
using a sample with half the number of observations (cf. Finan et al., 2010).
It is important to note the limitations of this study. First, our findings are preliminary 
because of the small sample size and should be replicated in larger study populations. 
Second, analyzing different ancestry groups separately was not possible due to sample size, 
although our findings were very similar when excluding non-White participants. Further, 
though the SNPs of focus were selected due to their empirical importance for the processes 
of interest, this limited number of SNPs does not reflect the likelihood that daily fluctuations 
in pain may be influenced by multiple genes.
In conclusion, the current study takes an ambulatory approach to investigating genotypic 
differences in the dynamics of pain and activity in the daily lives of patients with knee OA. 
Addressing emergent questions about the role of genetic risk for pain sensitivity in a 
potential feedback loop of daily pain and activity will be important for a more complete 
understanding of how knee OA evolves in this rapidly growing clinical population.
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Perspective
This study provides preliminary evidence that patients with certain variations in the 
COMT and OPRM1 SNPs experience more variability in their day-to-day pain and 
exacerbation of pain after daily physical activity.
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Figure 1. 
The moderating effect of COMT rs4680 in the association between minutes of afternoon 
moderate activity and end-of-day pain severity. Estimated values are presented for the 
within-person association between physical activity and knee pain for patients with one or 
more copies of the Met158 allele (A-A or A-G) and patients with two copies of the Val158 
allele (G-G), at three levels of physical activity (i.e., the sample average of within-person 
means and one standard deviation above and below the average, or approximately 15 
minutes).
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Table 1
Sample Characteristics (N = 120)
Variable M (SD) or %
Age 65.9 (9.9)
Sex = male 51%
Years of education 16.0 (2.1)
Ethnicity = White 88%
Employed 38%
Household income $40,000-59,000
Duration of knee OA (years) 12.8 (11.2)
Arthritis severity (WOMAC) 34.9 (14.7)
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Table 2
Genotype Frequencies
Genotype Frequency
OPRM1 rs1799971 (Asn40Asp)
  A-A (Asn/Asn) 0.746
  A-G (Asn/Asp) 0.254
COMT rs4680 (Val158Met)
  A-A (Met/Met) 0.275
  A-G (Met/Val) 0.458
  G-G (Val/Val) 0.267
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Table 3
Differences in Within-Person Daily Knee Pain Variability by COMT rs4680, and OPRM1 rs1799971
Daily Knee Pain COMT P-value OPRM1 P-value
Estimate (SE) Estimate (SE)
Beginning of Day −0.11 (0.07) .160 0.21 (0.08) .009
Afternoon −0.24 (0.07) .001 0.13 (0.08) .084
End of Day −0.28 (0.07) .0002 0.18 (0.08) .028
Across the Day −0.15 (0.07) .030 0.15 (0.07) .037
Notes. Across the Day = average of beginning of day, afternoon, and end of day. All analyses control for age, race, sex, and day in study (i.e., 1 to 
22). Coding of COMT rs4680: G-G = 0; A-A, A-G = 1. Coding of OPRM1 rs1799971: A-G = 0, A-A = 1.
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Table 4
Multilevel Moderation Models of Lagged Associations between Physical Activity and Knee Pain by COMT 
rs4680 and OPRM1 rs1799971
COMT OPRM1
End of Day Pain End of Day Pain
Fixed Effects Estimate (SE) Estimate (SE)
Model for Afternoon Moderate Activity
 Intercept 1.942 0.485*** 2.214 0.528***
 Minutes of moderate physical activity 0.303 0.112** −0.055 0.093
 Genotype −0.027 0.155 −0.223 0.166
 Moderate activity × Genotype −0.306 0.124* 0.145 0.110
Model for Afternoon Step Count
 Intercept 1.939 0.485*** 2.215 0.528***
 Step count 0.004 0.002 −0.001 0.002
 Genotype −0.023 0.155 −0.219 0.167
 Steps × Genotype −0.002 0.003 0.005 0.003†
Notes. Minutes of moderate physical activity were scaled by 60, such that a one-unit increase is equivalent to 60 minutes. Steps were scaled by 100, 
such that a one-unit increase is equivalent to 100 steps. All analyses control for age, race, sex, and day in study (i.e., 1 to 22). Coding of COMT 
rs4680: G-G = 0; A-A, A-G = 1. Coding of OPRM1 rs1799971: A-G = 0, A-A = 1.
Npatients = 115 for COMT rs4680; 114 for OPRM1 rs1799971. Nobservations = up to 1496.
†
p = .085.
*
p <. 05.
**
p ≤.01.
***
p < .001.
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